A novel prostacyclin receptor agonist, selexipagZHANG Xin-fang, SUN Hui-juan, ZHU Mei-hua, WANG Li-li, LIU Zheng-ping, ZHANG Jian-qiang2161-2164
First orphan drug for hereditary factor X deficiency:coagadexZHAO Xiao-juan, ZHOU Li-ming, ZHAO Yong-hong2165-2167
Research on the first generic drug system and the patent challenge strategy of USALIN Tao-xi, YU Na, HUANG Lu2168-2173
Global regulatory requirement and development strategy for pediatric drugsHUANG Fang-hua, WANG Qing-li, Jim Ridings, Susan Watts, WANG Ying, ZHANG Yun2174-2182
Biological activity screening of DL0805 derivatives and the cytotoxicity evaluation袁天翊, 王夙博, 陈俞材, 张惠芳, 焦晓臻, 谢平, 方莲花, 杜冠华2183-2188
Safety evaluation of repeated intramuscular injection of CpG 684-HBV vaccine in rats刘丽, 王超, 林志, 孟建华, 李明, 苗玉发, 杨艳伟, 张翊, 邵彦2189-2198
The new direction in the development of antibiotics:anti-bacterial antibody drugsWANG Zhi-ming2199-2204
The status and prospect of research and development of drug combinationsCHEN Guang-liang, ZHANG Lei, CHEN Ping, XU Xi-ping2205-2210
Influencing factors of the protective RISK pathway of myocardial ischemia/reperfusion关月, 卫国, 段佳林, 殷英, 郭超, 朱艳荣, 王艳华, 奚苗苗, 文爱东2211-2217
Recent progress in research of pH-sensitive polymeric micelles as drug delivery system王狄狮, 周艳霞, 李承洧, 屈小又, 王子琪, 李馨儒, 易崇勤, 刘艳2218-2224